• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. COBALT CEMENT; COBALT G-HV BONE CEMENT 40GM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. COBALT CEMENT; COBALT G-HV BONE CEMENT 40GM Back to Search Results
Model Number 600-15-100
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 02/22/2019
Type of Reportable Event Malfunction
Event or Problem Description
Complaint - while opening the cobalt cement, sterile pack opened unintentionally.
 
Additional Manufacturer Narrative
Manufacturer narrative: the reason for this complaint was due to the sterile pack opening unintentionally when opening cobalt packaging.This event occurred during surgery, away from the patient and the agent was not present.There was no delay in surgery and no adverse event was reported and there was another suitable unit available.Manufacture of cobalt bone cement was recently transitioned from zimmer biomet to osartis.Shipments were received from osartis beginning (b)(6) 2018.Product was shipped to djo customers and consignment locations beginning (b)(6) 2018.3 customer complaints have been received in september 2018 reporting problems with the new packaging.The outer pouch of the powder is designed to tear open at the top.When the customer tears the package, they may tear the inner sterile pouch resulting in a loss of the sterility of the cement copolymer powder.A review of the device history record (dhr) revealed no discrepancies or issues with the manufacturing history of this part.All parts conformed to design and manufacturing specifications at the time of manufacture.No (non-conforming material reports) ncmr's were associated with this part.Due to 3 complaints being received in a short amount of time and the possibility of increased patient risk, (health hazard evaluation) hhe-2018-00007 will be performed to assess patient risk related to this issue.(corrective action preventative action) capa (b)(4) has been opened to investigate root cause and determine corrective action.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBALT CEMENT
Common Device Name
COBALT G-HV BONE CEMENT 40GM
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin TX 78758 5445
MDR Report Key8441416
Report Number1644408-2019-00215
Device Sequence Number1663959
Product Code LOD
UDI-Device Identifier00190446138013
UDI-Public(01)00190446138013
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K051532
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 04/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number600-15-100
Device Catalogue Number600-15-100
Device Lot Number820C1
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/22/2019
Supplement Date Received by Manufacturer04/12/2019
Initial Report FDA Received Date03/21/2019
Supplement Report FDA Received Date04/17/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
600-15-100, LOT 820C2.; 600-15-100, LOT 820C2.
Outcome Attributed to Adverse Event Other;
-
-